Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.

MLA

Mallawaarachchi, Sumudu Rasangi, et al. “Cognitive Functioning in Ultra-High Risk for Psychosis Individuals with and without Depression: Secondary Analysis of Findings from the NEURAPRO Randomized Clinical Trial.” Schizophrenia Research, vol. 218, Apr. 2020, pp. 48–54. EBSCOhost, https://doi.org/10.1016/j.schres.2020.03.008.

APA

Mallawaarachchi, S. R., Amminger, G. P., Farhall, J., Bolt, L. K., Nelson, B., Yuen, H. P., McGorry, P. D., Markulev, C., Schäfer, M. R., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G. E., Chen, E. Y. H., de Haan, L., Nieman, D. H., Nordentoft, M., Riecher-Rössler, A., … Allott, K. A. (2020). Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial. Schizophrenia Research, 218, 48–54. https://doi.org/10.1016/j.schres.2020.03.008

Chicago

Mallawaarachchi, Sumudu Rasangi, G Paul Amminger, John Farhall, Luke K Bolt, Barnaby Nelson, Hok Pan Yuen, Patrick D McGorry, et al. 2020. “Cognitive Functioning in Ultra-High Risk for Psychosis Individuals with and without Depression: Secondary Analysis of Findings from the NEURAPRO Randomized Clinical Trial.” Schizophrenia Research 218 (April): 48–54. doi:10.1016/j.schres.2020.03.008.